Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

SAB Biotherapeutics Inc. (SABS)

5.87   -0.88 (-13.04%) 01-19 08:23
Open: 6.71 Pre. Close: 6.75
High: 6.71 Low: 5.83
Volume: 167,711 Market Cap: 255M
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing immunotherapeutic human antibodies. The company applies advanced genetic engineering and antibody science to develop transchromosomic (Tc) Bovine that produce human antibodies targeted at specific diseases, including infectious diseases, such as COVID-19 and influenza; immune system disorders, including type 1 diabetes and organ transplantation; and cancer. Its DiversitAb platform is applicable to a range of human diseases. The company was founded in 2014 and is headquartered in Sioux Falls, South Dakota.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.72 - 6.767 6.767 - 6.803
Low: 5.721 - 5.777 5.777 - 5.821
Close: 5.792 - 5.868 5.868 - 5.927

Technical analysis

as of: 2022-01-18 4:34:09 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 9.99     One year: 11.95
Support: Support1: 5.83    Support2: 4.85
Resistance: Resistance1: 8.55    Resistance2: 10.23
Pivot: 7.69
Moving Average: MA(5): 6.99     MA(20): 7.94
MA(100): 9.32     MA(250):
MACD: MACD(12,26): -0.64     Signal(9): -0.48
Stochastic oscillator: %K(14,3): 7.14     %D(3): 17.31
RSI: RSI(14): 26.91
52-week: High: 12.90  Low: 5.83  Change(%): -42.2
Average Vol(K): 3-Month: 41891  10-Days: 12107

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
SABS has closed below the lower band by 12.7%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 55.6% wider than normal. The large width of the bands suggest high volatility as compared to SABS's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.

Headline News

Sat, 08 Jan 2022
SAB Biotherapeutics Inc Shares Near 52-Week Low - Market Mover - Nasdaq

Wed, 05 Jan 2022
SAB Biotherapeutics to Present at 2022 HC Wainwright BioConnect Virtual Conference - GlobeNewswire

Mon, 20 Dec 2021
SAB Biotherapeutics Added to NASDAQ Biotechnology Index - GlobeNewswire

Mon, 20 Dec 2021
Where Does Wall Street Think SAB Biotherapeutics Inc (SABS) Stock Will Go? - InvestorsObserver

Thu, 16 Dec 2021
SAB Biotherapeutics Announces SAB-185 Retains Neutralization Against Omicron SARS-CoV-2 Variant In Vitro - Yahoo Finance

Thu, 02 Dec 2021
SAB Biotherapeutics: Advancing A New Class Of Immunotherapies Leveraging Polyclonal Antibodies - Seeking Alpha

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 43
Shares Float (M) 20
% Held by Insiders 42.46
% Held by Institutions 24.70
Shares Short (K) 545
Shares Short P. Month (K) 197

Stock Financials

EPS -0.010
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin 3.77
Operating Margin 3.35
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth -16.0
Gross Profit (p.s.) 0.629
Sales Per Share 1.738
EBITDA (p.s.) 0.082
Qtrly Earnings Growth
Operating Cash Flow (M) 11
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio -587.00
PEG Ratio
Price to Book value 5.87
Price to Sales 3.38
Price to Cash Flow 22.38

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.